speb/financial-data huggingface dataset:
XRA.AX balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 75564.00
XRA.AX balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 75564.00
XRA.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 525077.00
XRA.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 46284.00
XRA.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 46284.00
XRA.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 46284.00
XRA.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 4819724.00
XRA.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.64
XRA.AX income_statement (annual, 2023-06-30) — EBIT: -3066871.00
XRA.AX income_statement (annual, 2023-06-30) — EBITDA: -3020587.00
XRA.AX cash_flow (annual, 2023-06-30) — End Cash Position: 2666452.00
XRA.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 1263313.00
XRA.AX balance_sheet (annual, 2023-06-30) — Fixed Assets Revaluation Reserve: -316089.00
XRA.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -3077180.00
XRA.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 404963.00
XRA.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 948646.00
XRA.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 6158077.00
XRA.AX income_statement (annual, 2023-06-30) — Interest Expense: 9544.00
XRA.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 9544.00
XRA.AX income_statement (annual, 2023-06-30) — Interest Income: 106624.00
XRA.AX income_statement (annual, 2023-06-30) — Interest Income Non Operating: 106624.00
XRA.AX cash_flow (annual, 2023-06-30) — Interest Paid Direct: -9544.00
XRA.AX cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 9544.00
XRA.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 103668.00
XRA.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 8650180.00
XRA.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -139539.00
XRA.AX balance_sheet (annual, 2023-06-30) — Investments And Advances: 183911.00
XRA.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 1418011.00
XRA.AX balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 154112.00
XRA.AX balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 154112.00
XRA.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 177509.00
XRA.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 1301841.00
XRA.AX income_statement (annual, 2023-06-30) — Net Income: -3076415.00
XRA.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -3076415.00
XRA.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -3076415.00
XRA.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -3076415.00
XRA.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -3076415.00
XRA.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -3076415.00
XRA.AX income_statement (annual, 2023-06-30) — Net Interest Income: 97080.00
XRA.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: 97080.00
XRA.AX cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -63376.00
XRA.AX cash_flow (annual, 2023-06-30) — Net Other Investing Changes: -124993.00
XRA.AX balance_sheet (annual, 2023-06-30) — Net PPE: 6097953.00
XRA.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -14546.00
XRA.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 8650180.00
XRA.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: -3020587.00
XRA.AX income_statement (annual, 2023-06-30) — Normalized Income: -3076415.00
XRA.AX income_statement (annual, 2023-06-30) — Operating Income: -3173495.00
XRA.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 5130295.00
XRA.AX cash_flow (annual, 2023-06-30) — Other Cash Paymentsfrom Operating Activities: -1841377.00
XRA.AX balance_sheet (annual, 2023-06-30) — Other Current Assets: 206872.00
XRA.AX balance_sheet (annual, 2023-06-30) — Other Current Liabilities: 30000.00
XRA.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 721052.00
XRA.AX income_statement (annual, 2023-06-30) — Other Gand A: 310831.00
XRA.AX balance_sheet (annual, 2023-06-30) — Other Investments: 183911.00
XRA.AX balance_sheet (annual, 2023-06-30) — Other Non Current Assets: 111793.00
XRA.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 2134298.00
XRA.AX balance_sheet (annual, 2023-06-30) — Other Payable: 67309.00
XRA.AX balance_sheet (annual, 2023-06-30) — Other Properties: 5980568.00
XRA.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 17715.00
XRA.AX balance_sheet (annual, 2023-06-30) — Payables: 267654.00
XRA.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 267654.00
XRA.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -1315381.00
XRA.AX balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 151859.00
XRA.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 44673.00
XRA.AX income_statement (annual, 2023-06-30) — Pretax Income: -3076415.00
XRA.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -14546.00
XRA.AX balance_sheet (annual, 2023-06-30) — Receivables: 17715.00
XRA.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 46284.00
XRA.AX income_statement (annual, 2023-06-30) — Rent And Landing Fees: 68409.00
XRA.AX cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -116170.00
XRA.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -27976568.00
XRA.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 569406.00
XRA.AX income_statement (annual, 2023-06-30) — Selling And Marketing Expense: 44267.00
XRA.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 992913.00
XRA.AX balance_sheet (annual, 2023-06-30) — Share Issued: 5130295.00
XRA.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 8650180.00
XRA.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 8650180.00
XRA.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
XRA.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
XRA.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
XRA.AX balance_sheet (annual, 2023-06-30) — Total Assets: 9329369.00
XRA.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 8650180.00
XRA.AX balance_sheet (annual, 2023-06-30) — Total Debt: 229676.00
XRA.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 8650180.00
XRA.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 679189.00
XRA.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 6393657.00
XRA.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 154112.00
XRA.AX balance_sheet (annual, 2023-06-30) — Working Capital: 2410635.00
XRA.AX income_statement (annual, 2024-06-30) — +Operating Expense: 5019690.00
XRA.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 1044765.00
XRA.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -156604.00
XRA.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 9646663.00
XRA.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.51
XRA.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 2666452.00
XRA.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -1749091.00
XRA.AX cash_flow (annual, 2024-06-30) — Capital Expenditure Reported: -1749091.00
XRA.AX balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 154113.00
XRA.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 45939707.00
XRA.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 2803274.00
XRA.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 2803274.00
XRA.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 2803274.00
XRA.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 5589230.00
XRA.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -1905448.00
XRA.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -3573947.00
XRA.AX cash_flow (annual, 2024-06-30) — Changes In Cash: 109835.00
XRA.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -5909418.00
XRA.AX balance_sheet (annual, 2024-06-30) — Common Stock: 45939707.00
XRA.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 15233181.00
XRA.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 6050000.00
XRA.AX cash_flow (annual, 2024-06-30) — Common Stock Payments: -380844.00
XRA.AX balance_sheet (annual, 2024-06-30) — Current Assets: 3308749.00
XRA.AX balance_sheet (annual, 2024-06-30) — Current Capital Lease Obligation: 72301.00
XRA.AX balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 72301.00
XRA.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 1473286.00
XRA.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 96552.00
XRA.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 96552.00
XRA.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 96552.00
XRA.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 9646663.00
XRA.AX income_statement (annual, 2024-06-30) — Diluted EPS: -0.51
XRA.AX income_statement (annual, 2024-06-30) — EBIT: -4905360.00
XRA.AX income_statement (annual, 2024-06-30) — EBITDA: -4808808.00
XRA.AX cash_flow (annual, 2024-06-30) — Effect Of Exchange Rate Changes: 26987.00
XRA.AX cash_flow (annual, 2024-06-30) — End Cash Position: 2803274.00
XRA.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 5589230.00
XRA.AX balance_sheet (annual, 2024-06-30) — Fixed Assets Revaluation Reserve: -396773.00
XRA.AX balance_sheet (annual, 2024-06-30) — Foreign Currency Translation Adjustments: 26988.00
XRA.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -5323038.00
XRA.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 1827928.00
XRA.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 1068659.00
XRA.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 13532907.00
XRA.AX income_statement (annual, 2024-06-30) — Interest Expense: 21650.00
XRA.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 21650.00
XRA.AX income_statement (annual, 2024-06-30) — Interest Income: 114330.00
XRA.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 114330.00
XRA.AX cash_flow (annual, 2024-06-30) — Interest Paid Direct: -21650.00
XRA.AX cash_flow (annual, 2024-06-30) — Interest Paid Supplemental Data: 21650.00
XRA.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 115872.00
XRA.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 15233181.00
XRA.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -1905448.00
XRA.AX balance_sheet (annual, 2024-06-30) — Investments And Advances: 103227.00
XRA.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 6050000.00
XRA.AX balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 81812.00
XRA.AX balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 81812.00
XRA.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 177009.00
XRA.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 5669156.00
XRA.AX income_statement (annual, 2024-06-30) — Net Income: -4927010.00
XRA.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -4927010.00
XRA.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -4927010.00
XRA.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -4927010.00
XRA.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -4927010.00
XRA.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -4927010.00
XRA.AX income_statement (annual, 2024-06-30) — Net Interest Income: 92680.00
XRA.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: 92680.00
XRA.AX cash_flow (annual, 2024-06-30) — Net Other Financing Charges: -155489.00
XRA.AX cash_flow (annual, 2024-06-30) — Net Other Investing Changes: -156357.00
XRA.AX balance_sheet (annual, 2024-06-30) — Net PPE: 13376303.00
XRA.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 15233181.00
XRA.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -4808808.00
XRA.AX income_statement (annual, 2024-06-30) — Normalized Income: -4927010.00
XRA.AX income_statement (annual, 2024-06-30) — Operating Income: -5019690.00
XRA.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 14398836.00
XRA.AX cash_flow (annual, 2024-06-30) — Other Cash Paymentsfrom Operating Activities: -2241249.00
XRA.AX balance_sheet (annual, 2024-06-30) — Other Current Assets: 363230.00
XRA.AX balance_sheet (annual, 2024-06-30) — Other Current Liabilities: 25637.00
XRA.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 2197713.00
XRA.AX income_statement (annual, 2024-06-30) — Other Gand A: 310857.00
XRA.AX balance_sheet (annual, 2024-06-30) — Other Investments: 103227.00
XRA.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 3758257.00
XRA.AX balance_sheet (annual, 2024-06-30) — Other Payable: 137728.00
XRA.AX balance_sheet (annual, 2024-06-30) — Other Properties: 13355898.00
XRA.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 52833.00
XRA.AX balance_sheet (annual, 2024-06-30) — Payables: 1182493.00
XRA.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 1182493.00
XRA.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -3668169.00
XRA.AX balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 192855.00
XRA.AX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 89412.00
XRA.AX income_statement (annual, 2024-06-30) — Pretax Income: -4927010.00
XRA.AX balance_sheet (annual, 2024-06-30) — Receivables: 52833.00
XRA.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 96552.00
XRA.AX income_statement (annual, 2024-06-30) — Rent And Landing Fees: 14022.00
XRA.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -380844.00
XRA.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -32534454.00
XRA.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 743780.00
XRA.AX income_statement (annual, 2024-06-30) — Selling And Marketing Expense: 96222.00
XRA.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 1164881.00
XRA.AX balance_sheet (annual, 2024-06-30) — Share Issued: 14398836.00
XRA.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 15233181.00
XRA.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 15233181.00
XRA.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
XRA.AX income_statement (annual, 2024-06-30) — Tax Provision: 0.00
XRA.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
XRA.AX balance_sheet (annual, 2024-06-30) — Total Assets: 16788279.00
XRA.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 15233181.00
XRA.AX balance_sheet (annual, 2024-06-30) — Total Debt: 154113.00
XRA.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 15233181.00
XRA.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 1555098.00
XRA.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 13479530.00
XRA.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 81812.00
XRA.AX balance_sheet (annual, 2024-06-30) — Working Capital: 1835463.00
XRA.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 117591.00
XRA.AX income_statement (annual, 2025-06-30) — Basic EPS: -58.55
XRA.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 117591.00
XRA.AX income_statement (annual, 2025-06-30) — Diluted EPS: -58.55
XRAY cash_flow (annual, 2021-12-31) — Changes In Account Receivables: -117000000.00
XRAY cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -92000000.00
XRAY income_statement (annual, 2021-12-31) — Earnings From Equity Interest: -10000000.00
XRAY cash_flow (annual, 2021-12-31) — Earnings Losses From Equity Investments: 10000000.00
XRAY cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -14000000.00
XRAY income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 7000000.00
XRAY income_statement (annual, 2021-12-31) — General And Administrative Expense: 1551000000.00
XRAY cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: 0.00
XRAY cash_flow (annual, 2021-12-31) — Operating Gains Losses: -4000000.00
XRAY income_statement (annual, 2021-12-31) — Other Gand A: 1551000000.00
XRAY balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 172000000.00
XRAY cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 51000000.00
XRAY cash_flow (annual, 2021-12-31) — Purchase Of Business: -248000000.00
XRAY cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
XRAY cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 179000000.00
XRAY income_statement (annual, 2022-12-31) — +Operating Expense: 1763000000.00
XRAY income_statement (annual, 2022-12-31) — +Total Revenue: 3922000000.00
XRAY balance_sheet (annual, 2022-12-31) — Accounts Payable: 279000000.00
XRAY balance_sheet (annual, 2022-12-31) — Accounts Receivable: 632000000.00
XRAY balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1312000000.00
XRAY balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 6629000000.00
XRAY balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -14000000.00
XRAY cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 209000000.00
XRAY cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 209000000.00
XRAY cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 1287000000.00
XRAY income_statement (annual, 2022-12-31) — Basic Average Shares: 215500000.00
XRAY income_statement (annual, 2022-12-31) — Basic EPS: -4.41
XRAY cash_flow (annual, 2022-12-31) — Beginning Cash Position: 339000000.00
XRAY balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 546000000.00
XRAY cash_flow (annual, 2022-12-31) — Capital Expenditure: -149000000.00
XRAY cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -149000000.00
XRAY balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 203000000.00
XRAY balance_sheet (annual, 2022-12-31) — Capital Stock: 3000000.00
XRAY balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 365000000.00
XRAY balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 365000000.00
XRAY cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -104000000.00
XRAY cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -329000000.00
XRAY cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -138000000.00
XRAY cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 517000000.00
XRAY cash_flow (annual, 2022-12-31) — Change In Account Payable: 30000000.00
XRAY cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -6000000.00
XRAY cash_flow (annual, 2022-12-31) — Change In Inventory: -141000000.00
XRAY cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 1000000.00
XRAY cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 1000000.00
XRAY cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -15000000.00
XRAY cash_flow (annual, 2022-12-31) — Change In Payable: 30000000.00
XRAY cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 24000000.00
XRAY cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -33000000.00
XRAY cash_flow (annual, 2022-12-31) — Change In Receivables: 85000000.00
XRAY cash_flow (annual, 2022-12-31) — Change In Working Capital: -78000000.00
XRAY cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 85000000.00
XRAY cash_flow (annual, 2022-12-31) — Changes In Cash: 50000000.00
XRAY balance_sheet (annual, 2022-12-31) — Commercial Paper: 95000000.00
XRAY balance_sheet (annual, 2022-12-31) — Common Stock: 3000000.00
XRAY balance_sheet (annual, 2022-12-31) — Common Stock Equity: 3811000000.00
XRAY cash_flow (annual, 2022-12-31) — Common Stock Payments: -150000000.00
XRAY balance_sheet (annual, 2022-12-31) — Construction In Progress: 116000000.00
XRAY income_statement (annual, 2022-12-31) — Cost Of Revenue: 1795000000.00
XRAY balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 401000000.00
XRAY balance_sheet (annual, 2022-12-31) — Current Assets: 1893000000.00
XRAY balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 54000000.00
XRAY balance_sheet (annual, 2022-12-31) — Current Debt: 118000000.00
XRAY balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 172000000.00
XRAY balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 84000000.00
XRAY balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 84000000.00
XRAY balance_sheet (annual, 2022-12-31) — Current Liabilities: 1170000000.00
XRAY balance_sheet (annual, 2022-12-31) — Current Provisions: 163000000.00
XRAY cash_flow (annual, 2022-12-31) — Deferred Income Tax: -228000000.00
XRAY cash_flow (annual, 2022-12-31) — Deferred Tax: -228000000.00
XRAY cash_flow (annual, 2022-12-31) — Depreciation: 119000000.00
XRAY cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 328000000.00
XRAY cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 328000000.00
XRAY income_statement (annual, 2022-12-31) — Diluted Average Shares: 215500000.00
XRAY income_statement (annual, 2022-12-31) — Diluted EPS: -4.41
XRAY income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -950000000.00
XRAY income_statement (annual, 2022-12-31) — EBIT: -990000000.00
XRAY income_statement (annual, 2022-12-31) — EBITDA: -662000000.00
XRAY income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -36000000.00
XRAY cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 36000000.00
XRAY cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -24000000.00
XRAY cash_flow (annual, 2022-12-31) — End Cash Position: 365000000.00
XRAY cash_flow (annual, 2022-12-31) — Financing Cash Flow: -329000000.00
XRAY balance_sheet (annual, 2022-12-31) — Finished Goods: 381000000.00
XRAY cash_flow (annual, 2022-12-31) — Free Cash Flow: 368000000.00
XRAY cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 3000000.00
XRAY cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 3000000.00
XRAY income_statement (annual, 2022-12-31) — Gain On Sale Of Business: -3000000.00
XRAY income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -6000000.00
XRAY balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -628000000.00
XRAY income_statement (annual, 2022-12-31) — General And Administrative Expense: 1596000000.00
XRAY balance_sheet (annual, 2022-12-31) — Goodwill: 2688000000.00
XRAY balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 4591000000.00
XRAY balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 646000000.00
XRAY balance_sheet (annual, 2022-12-31) — Gross PPE: 2273000000.00
XRAY income_statement (annual, 2022-12-31) — Gross Profit: 2127000000.00
XRAY income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 1287000000.00
XRAY cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 122000000.00
XRAY balance_sheet (annual, 2022-12-31) — Income Tax Payable: 46000000.00
XRAY income_statement (annual, 2022-12-31) — Interest Expense: 65000000.00
XRAY income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 65000000.00
XRAY cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 70000000.00
XRAY balance_sheet (annual, 2022-12-31) — Interest Payable: 9000000.00
XRAY balance_sheet (annual, 2022-12-31) — Inventory: 627000000.00
XRAY balance_sheet (annual, 2022-12-31) — Invested Capital: 5755000000.00
XRAY cash_flow (annual, 2022-12-31) — Investing Cash Flow: -138000000.00
XRAY cash_flow (annual, 2022-12-31) — Issuance Of Debt: 6000000.00
XRAY balance_sheet (annual, 2022-12-31) — Land And Improvements: 48000000.00
XRAY balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 149000000.00
XRAY balance_sheet (annual, 2022-12-31) — Long Term Debt: 1826000000.00
XRAY balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1975000000.00
XRAY cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 6000000.00
XRAY cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -2000000.00
XRAY balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1363000000.00
XRAY balance_sheet (annual, 2022-12-31) — Minority Interest: 1000000.00
XRAY income_statement (annual, 2022-12-31) — Minority Interests: 0.00
XRAY cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
XRAY cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -150000000.00
XRAY balance_sheet (annual, 2022-12-31) — Net Debt: 1579000000.00
XRAY income_statement (annual, 2022-12-31) — Net Income: -950000000.00
XRAY income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -950000000.00
XRAY income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -950000000.00
XRAY income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -950000000.00
XRAY income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -950000000.00
XRAY cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -950000000.00
XRAY income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -950000000.00
XRAY income_statement (annual, 2022-12-31) — Net Interest Income: -65000000.00
XRAY cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 13000000.00
XRAY cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -60000000.00
XRAY cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 4000000.00
XRAY income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -65000000.00
XRAY cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -15000000.00
XRAY cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -2000000.00
XRAY balance_sheet (annual, 2022-12-31) — Net PPE: 961000000.00
XRAY cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 0.00
XRAY cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -64000000.00
XRAY balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -780000000.00
XRAY balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 287000000.00
XRAY balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 287000000.00
XRAY income_statement (annual, 2022-12-31) — Normalized EBITDA: 645000000.00
XRAY income_statement (annual, 2022-12-31) — Normalized Income: 227607000.00
XRAY cash_flow (annual, 2022-12-31) — Operating Cash Flow: 517000000.00
XRAY cash_flow (annual, 2022-12-31) — Operating Gains Losses: 39000000.00
XRAY income_statement (annual, 2022-12-31) — Operating Income: 364000000.00
XRAY income_statement (annual, 2022-12-31) — Operating Revenue: 3922000000.00
XRAY balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 215300000.00
XRAY balance_sheet (annual, 2022-12-31) — Other Current Assets: 88000000.00
XRAY balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 23000000.00
XRAY balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 19000000.00
XRAY balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -628000000.00
XRAY income_statement (annual, 2022-12-31) — Other Gand A: 1589000000.00
XRAY income_statement (annual, 2022-12-31) — Other Income Expense: -1354000000.00
XRAY balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1903000000.00
XRAY cash_flow (annual, 2022-12-31) — Other Non Cash Items: 60000000.00
XRAY balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 198000000.00
XRAY balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 399000000.00
XRAY income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -11000000.00
XRAY balance_sheet (annual, 2022-12-31) — Other Properties: 200000000.00
XRAY balance_sheet (annual, 2022-12-31) — Payables: 331000000.00
XRAY balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 732000000.00
XRAY balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
XRAY balance_sheet (annual, 2022-12-31) — Prepaid Assets: 128000000.00
XRAY income_statement (annual, 2022-12-31) — Pretax Income: -1055000000.00
XRAY cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 6000000.00
XRAY balance_sheet (annual, 2022-12-31) — Properties: 0.00
XRAY cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
XRAY cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
XRAY balance_sheet (annual, 2022-12-31) — Raw Materials: 169000000.00
XRAY balance_sheet (annual, 2022-12-31) — Receivables: 685000000.00
XRAY income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1795000000.00
XRAY income_statement (annual, 2022-12-31) — Reconciled Depreciation: 328000000.00
XRAY cash_flow (annual, 2022-12-31) — Repayment Of Debt: -2000000.00
XRAY cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -150000000.00
XRAY income_statement (annual, 2022-12-31) — Research And Development: 174000000.00
XRAY income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 14000000.00
XRAY balance_sheet (annual, 2022-12-31) — Retained Earnings: 456000000.00
XRAY income_statement (annual, 2022-12-31) — Salaries And Wages: 7000000.00
XRAY cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
XRAY cash_flow (annual, 2022-12-31) — Sale Of Investment: 13000000.00
XRAY cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
XRAY income_statement (annual, 2022-12-31) — Selling General And Administration: 1589000000.00
XRAY balance_sheet (annual, 2022-12-31) — Share Issued: 264600000.00
XRAY cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -64000000.00
XRAY income_statement (annual, 2022-12-31) — Special Income Charges: -1301000000.00
XRAY cash_flow (annual, 2022-12-31) — Stock Based Compensation: 59000000.00
XRAY balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3811000000.00
XRAY balance_sheet (annual, 2022-12-31) — Tangible Book Value: -780000000.00
XRAY income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -129393000.00
XRAY income_statement (annual, 2022-12-31) — Tax Provision: -105000000.00
XRAY income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.10
XRAY balance_sheet (annual, 2022-12-31) — Taxes Receivable: 53000000.00
XRAY balance_sheet (annual, 2022-12-31) — Total Assets: 7643000000.00
XRAY balance_sheet (annual, 2022-12-31) — Total Capitalization: 5637000000.00
XRAY balance_sheet (annual, 2022-12-31) — Total Debt: 2147000000.00
XRAY balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3812000000.00
XRAY income_statement (annual, 2022-12-31) — Total Expenses: 3558000000.00
XRAY balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3831000000.00
XRAY balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 5750000000.00
XRAY balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 2661000000.00
XRAY income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -937000000.00
XRAY balance_sheet (annual, 2022-12-31) — Total Tax Payable: 52000000.00
XRAY income_statement (annual, 2022-12-31) — Total Unusual Items: -1307000000.00
XRAY income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1307000000.00
XRAY balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 49300000.00
XRAY balance_sheet (annual, 2022-12-31) — Treasury Stock: 2649000000.00
XRAY balance_sheet (annual, 2022-12-31) — Work In Process: 77000000.00
XRAY balance_sheet (annual, 2022-12-31) — Working Capital: 723000000.00
XRAY income_statement (annual, 2023-12-31) — +Operating Expense: 1797000000.00
XRAY income_statement (annual, 2023-12-31) — +Total Revenue: 3965000000.00
XRAY balance_sheet (annual, 2023-12-31) — Accounts Payable: 305000000.00
XRAY balance_sheet (annual, 2023-12-31) — Accounts Receivable: 695000000.00
XRAY balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1365000000.00
XRAY balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 6643000000.00
XRAY balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -17000000.00
XRAY cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 211000000.00
XRAY cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 211000000.00
XRAY cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 307000000.00
XRAY income_statement (annual, 2023-12-31) — Basic Average Shares: 212000000.00
XRAY income_statement (annual, 2023-12-31) — Basic EPS: -0.62
XRAY cash_flow (annual, 2023-12-31) — Beginning Cash Position: 365000000.00
XRAY balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 568000000.00
XRAY cash_flow (annual, 2023-12-31) — Capital Expenditure: -149000000.00
XRAY cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -149000000.00
XRAY balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 181000000.00
XRAY balance_sheet (annual, 2023-12-31) — Capital Stock: 3000000.00
XRAY balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 334000000.00
XRAY balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 334000000.00
XRAY cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -116000000.00
XRAY cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -307000000.00
XRAY cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -89000000.00
XRAY cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 377000000.00
XRAY cash_flow (annual, 2023-12-31) — Change In Account Payable: 14000000.00
XRAY cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 17000000.00
XRAY cash_flow (annual, 2023-12-31) — Change In Inventory: 6000000.00
XRAY cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 4000000.00
XRAY cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 30000000.00
XRAY cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -11000000.00
XRAY cash_flow (annual, 2023-12-31) — Change In Payable: 14000000.00
XRAY cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 31000000.00
XRAY cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -58000000.00
XRAY cash_flow (annual, 2023-12-31) — Change In Receivables: -58000000.00
XRAY cash_flow (annual, 2023-12-31) — Change In Working Capital: -56000000.00
XRAY cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -58000000.00
XRAY cash_flow (annual, 2023-12-31) — Changes In Cash: -19000000.00
XRAY balance_sheet (annual, 2023-12-31) — Commercial Paper: 225000000.00
XRAY balance_sheet (annual, 2023-12-31) — Common Stock: 3000000.00
XRAY balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3293000000.00
XRAY cash_flow (annual, 2023-12-31) — Common Stock Payments: -300000000.00
XRAY balance_sheet (annual, 2023-12-31) — Construction In Progress: 138000000.00
XRAY income_statement (annual, 2023-12-31) — Cost Of Revenue: 1879000000.00
XRAY balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 427000000.00
XRAY balance_sheet (annual, 2023-12-31) — Current Assets: 1973000000.00
XRAY balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 56000000.00
XRAY balance_sheet (annual, 2023-12-31) — Current Debt: 322000000.00
XRAY balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 378000000.00
XRAY balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 91000000.00
XRAY balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 91000000.00
XRAY balance_sheet (annual, 2023-12-31) — Current Liabilities: 1425000000.00
XRAY balance_sheet (annual, 2023-12-31) — Current Provisions: 151000000.00
XRAY cash_flow (annual, 2023-12-31) — Deferred Income Tax: -130000000.00
XRAY cash_flow (annual, 2023-12-31) — Deferred Tax: -130000000.00
XRAY cash_flow (annual, 2023-12-31) — Depreciation: 132000000.00
XRAY cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 343000000.00
XRAY cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 343000000.00
XRAY income_statement (annual, 2023-12-31) — Diluted Average Shares: 212000000.00
XRAY income_statement (annual, 2023-12-31) — Diluted EPS: -0.62
XRAY income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -132000000.00
XRAY income_statement (annual, 2023-12-31) — EBIT: -94000000.00
XRAY income_statement (annual, 2023-12-31) — EBITDA: 249000000.00
XRAY income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -4000000.00
XRAY cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 4000000.00
XRAY cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -12000000.00
XRAY cash_flow (annual, 2023-12-31) — End Cash Position: 334000000.00
XRAY cash_flow (annual, 2023-12-31) — Financing Cash Flow: -307000000.00
XRAY balance_sheet (annual, 2023-12-31) — Finished Goods: 362000000.00
XRAY cash_flow (annual, 2023-12-31) — Free Cash Flow: 228000000.00
XRAY cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
XRAY cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -3000000.00
XRAY income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 0.00
XRAY income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 3000000.00
XRAY balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -636000000.00
XRAY income_statement (annual, 2023-12-31) — General And Administrative Expense: 1620000000.00
XRAY balance_sheet (annual, 2023-12-31) — Goodwill: 2438000000.00
XRAY balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 4143000000.00
XRAY balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 712000000.00
XRAY balance_sheet (annual, 2023-12-31) — Gross PPE: 2343000000.00
XRAY income_statement (annual, 2023-12-31) — Gross Profit: 2086000000.00
XRAY income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 307000000.00
XRAY cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 177000000.00
XRAY balance_sheet (annual, 2023-12-31) — Income Tax Payable: 49000000.00
XRAY income_statement (annual, 2023-12-31) — Interest Expense: 81000000.00
XRAY income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 81000000.00
XRAY cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 97000000.00
XRAY balance_sheet (annual, 2023-12-31) — Interest Payable: 9000000.00
XRAY balance_sheet (annual, 2023-12-31) — Inventory: 624000000.00
XRAY balance_sheet (annual, 2023-12-31) — Invested Capital: 5411000000.00
XRAY cash_flow (annual, 2023-12-31) — Investing Cash Flow: -89000000.00
XRAY cash_flow (annual, 2023-12-31) — Issuance Of Debt: 126000000.00
XRAY balance_sheet (annual, 2023-12-31) — Land And Improvements: 49000000.00
XRAY balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 125000000.00
XRAY balance_sheet (annual, 2023-12-31) — Long Term Debt: 1796000000.00
XRAY balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1921000000.00
XRAY cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
XRAY cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -7000000.00
XRAY balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1410000000.00
XRAY balance_sheet (annual, 2023-12-31) — Minority Interest: 1000000.00
XRAY income_statement (annual, 2023-12-31) — Minority Interests: 0.00
XRAY cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 13000000.00
XRAY cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -300000000.00
XRAY balance_sheet (annual, 2023-12-31) — Net Debt: 1784000000.00
XRAY income_statement (annual, 2023-12-31) — Net Income: -132000000.00
XRAY income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -132000000.00
XRAY income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -132000000.00
XRAY income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -132000000.00
XRAY income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -132000000.00
XRAY cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -132000000.00
XRAY income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -132000000.00
XRAY income_statement (annual, 2023-12-31) — Net Interest Income: -81000000.00
XRAY cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 39000000.00
XRAY cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 119000000.00
XRAY cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -7000000.00
XRAY income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -81000000.00
XRAY cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -10000000.00
XRAY cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 8000000.00
XRAY balance_sheet (annual, 2023-12-31) — Net PPE: 978000000.00
XRAY cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 7000000.00
XRAY cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 126000000.00
XRAY balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -850000000.00
XRAY balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 228000000.00
XRAY balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 228000000.00
XRAY income_statement (annual, 2023-12-31) — Normalized EBITDA: 620000000.00
XRAY income_statement (annual, 2023-12-31) — Normalized Income: 147840000.00
XRAY cash_flow (annual, 2023-12-31) — Operating Cash Flow: 377000000.00
XRAY cash_flow (annual, 2023-12-31) — Operating Gains Losses: -3000000.00
XRAY income_statement (annual, 2023-12-31) — Operating Income: 289000000.00
XRAY income_statement (annual, 2023-12-31) — Operating Revenue: 3965000000.00
XRAY balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 207200000.00
XRAY balance_sheet (annual, 2023-12-31) — Other Current Assets: 113000000.00
XRAY balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 97000000.00
XRAY balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 18000000.00
XRAY balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -636000000.00
XRAY income_statement (annual, 2023-12-31) — Other Gand A: 1613000000.00
XRAY income_statement (annual, 2023-12-31) — Other Income Expense: -383000000.00
XRAY balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 1705000000.00
XRAY cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2000000.00
XRAY balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 276000000.00
XRAY balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 502000000.00
XRAY income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -12000000.00
XRAY balance_sheet (annual, 2023-12-31) — Other Properties: 178000000.00
XRAY balance_sheet (annual, 2023-12-31) — Payables: 360000000.00
XRAY balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 787000000.00
XRAY balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
XRAY balance_sheet (annual, 2023-12-31) — Prepaid Assets: 146000000.00
XRAY income_statement (annual, 2023-12-31) — Pretax Income: -175000000.00
XRAY cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
XRAY balance_sheet (annual, 2023-12-31) — Properties: 0.00
XRAY cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
XRAY cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
XRAY balance_sheet (annual, 2023-12-31) — Raw Materials: 185000000.00
XRAY balance_sheet (annual, 2023-12-31) — Receivables: 756000000.00
XRAY income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1879000000.00
XRAY income_statement (annual, 2023-12-31) — Reconciled Depreciation: 343000000.00
XRAY cash_flow (annual, 2023-12-31) — Repayment Of Debt: -7000000.00
XRAY cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -300000000.00
XRAY income_statement (annual, 2023-12-31) — Research And Development: 184000000.00
XRAY income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 67000000.00
XRAY balance_sheet (annual, 2023-12-31) — Retained Earnings: 205000000.00
XRAY income_statement (annual, 2023-12-31) — Salaries And Wages: 7000000.00
XRAY cash_flow (annual, 2023-12-31) — Sale Of Business: 13000000.00
XRAY cash_flow (annual, 2023-12-31) — Sale Of Investment: 39000000.00
XRAY cash_flow (annual, 2023-12-31) — Sale Of PPE: 7000000.00
XRAY income_statement (annual, 2023-12-31) — Selling General And Administration: 1613000000.00
XRAY balance_sheet (annual, 2023-12-31) — Share Issued: 264500000.00
XRAY cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 126000000.00
XRAY cash_flow (annual, 2023-12-31) — Short Term Debt Payments: 0.00
XRAY income_statement (annual, 2023-12-31) — Special Income Charges: -374000000.00
XRAY cash_flow (annual, 2023-12-31) — Stock Based Compensation: 46000000.00
XRAY balance_sheet (annual, 2023-12-31) — Stockholders Equity: 3293000000.00
XRAY balance_sheet (annual, 2023-12-31) — Tangible Book Value: -850000000.00
XRAY income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -91160000.00
XRAY income_statement (annual, 2023-12-31) — Tax Provision: -43000000.00
XRAY income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.25
XRAY balance_sheet (annual, 2023-12-31) — Taxes Receivable: 61000000.00
XRAY balance_sheet (annual, 2023-12-31) — Total Assets: 7370000000.00
XRAY balance_sheet (annual, 2023-12-31) — Total Capitalization: 5089000000.00
XRAY balance_sheet (annual, 2023-12-31) — Total Debt: 2299000000.00
XRAY balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3294000000.00
XRAY income_statement (annual, 2023-12-31) — Total Expenses: 3676000000.00
XRAY balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 4076000000.00
XRAY balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 5397000000.00
XRAY balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 2651000000.00
XRAY income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -85000000.00
XRAY balance_sheet (annual, 2023-12-31) — Total Tax Payable: 55000000.00
XRAY income_statement (annual, 2023-12-31) — Total Unusual Items: -371000000.00
XRAY income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -371000000.00
XRAY balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 57300000.00
XRAY balance_sheet (annual, 2023-12-31) — Treasury Stock: 2922000000.00
XRAY balance_sheet (annual, 2023-12-31) — Work In Process: 77000000.00
XRAY balance_sheet (annual, 2023-12-31) — Working Capital: 548000000.00
XRAY cash_flow (quarterly, 2024-09-30) — Common Stock Dividend Paid: -33000000.00
XRAY cash_flow (quarterly, 2024-09-30) — Common Stock Payments: -100000000.00
XRAY balance_sheet (quarterly, 2024-09-30) — Current Notes Payable: 422000000.00
XRAY income_statement (quarterly, 2024-09-30) — Earnings From Equity Interest: 0.00
XRAY income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 391000000.00
XRAY cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
XRAY cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: -100000000.00
XRAY cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 0.00
XRAY income_statement (quarterly, 2024-09-30) — Other Gand A: 390000000.00
XRAY cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: -100000000.00
XRAY income_statement (quarterly, 2024-09-30) — Salaries And Wages: 1000000.00